C83.34 Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb

Name of the Condition

• Diffuse Large B-Cell Lymphoma, Lymph Nodes of Axilla and Upper Limb (ICD-10 Code: C83.34)

Summary

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma that originates in B-cells, a type of white blood cell. It is characterized by rapidly growing tumors in the lymph nodes or other lymphoid tissues. This code specifies involvement of the lymph nodes in the axilla (armpit) and upper limb regions. DLBCL is one of the most common subtypes of non-Hodgkin lymphoma and can occur in various parts of the body.

Causes

The exact cause of DLBCL is not fully understood. It is believed to result from genetic mutations in B-cells, which may be triggered by factors such as previous infections (e.g., Epstein-Barr virus), immune system dysfunctions, or exposure to certain environmental agents. These mutations disrupt normal cell growth and division, leading to uncontrolled proliferation.

Risk Factors

• Advanced age (most common in older adults)
• Weakened immune system (e.g., from HIV, organ transplants, or immunosuppressive drugs)
• Family history of lymphoma
• Exposure to certain chemicals or radiation
• Chronic infections (e.g., hepatitis C)

Symptoms

• Swollen, painless lymph nodes in the axilla or upper limb
• Unexplained weight loss
• Fever
• Night sweats
• Fatigue
• Loss of appetite
• Pain or swelling in the affected limb

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or PET scans), and biopsy of the affected lymph node. Laboratory tests, including blood work and flow cytometry, may also be used to confirm the diagnosis and assess disease extent.

Treatment Options

Treatment typically includes chemoimmunotherapy regimens such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). Radiation therapy may be used for localized disease, and stem cell transplantation is an option for relapsed or refractory cases. Targeted therapies and clinical trials may be considered for specific subtypes.

Prognosis and Follow-Up

Prognosis varies based on factors like age, overall health, and disease stage. Early-stage disease has a higher cure rate, while advanced or refractory cases may have a poorer outlook. Follow-up includes regular imaging, blood tests, and clinical assessments to monitor for recurrence or complications.

Complications

Potential complications include treatment-related side effects (e.g., infection, organ damage), disease progression, transformation to a more aggressive subtype, and long-term effects like secondary malignancies or infertility.

Lifestyle & Prevention

While prevention is not fully established, maintaining a healthy immune system through regular medical care, avoiding known carcinogens, and managing chronic infections may reduce risk. Supportive care, including nutrition and stress management, can improve quality of life during treatment.

When to Seek Professional Help

Seek medical attention for persistent swollen lymph nodes, unexplained weight loss, fever, or other symptoms listed above. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Use this code for diffuse large B-cell lymphoma specifically involving the lymph nodes of the axilla and upper limb. Ensure documentation supports the anatomical site to justify code assignment. Verify that the condition is not better classified under a more specific lymphoma code or a different ICD-10 category.